Dr. Iliopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom Street
Yaw 7 Massachusetts General Hospital
Boston, MA 02114Phone+1 617-724-3404Fax+1 617-726-8623
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1992 - 1996
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1992
- Johns Hopkins UniversityFellowship, Allergy and Immunology, 1985 - 1988
- University of AthensClass of 1985
Certifications & Licensure
- MA State Medical License 1992 - 2025
- WI State Medical License 1990 - 1993
Publications & Presentations
PubMed
- 96 citationsAssessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines.Sebastian Salas-Vega, Othon Iliopoulos, Elias Mossialos
JAMA Oncology. 2017-03-01 - 67 citationsHypoxia drives transient site-specific copy gain and drug-resistant gene expressionJoshua C. Black, Elnaz Atabakhsh, Jaegil Kim, Kelly M. Biette, Capucine Van Rechem
Genes & Development. 2015-05-15 - 1342 citationsReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxiaChristian M. Metallo, Paulo A. Gameiro, Eric L. Bell, Katherine R. Mattaini, Juanjuan Yang
Nature. 2012-01-19
Press Mentions
- Irp2 Regulates Insulin Production Through Iron-Mediated Cdkal1-Catalyzed tRNA ModificationJanuary 15th, 2020
- DF/HCC Kidney Cancer Program Symposium 2016May 20th, 2016
- Q&A with M. Celeste Simon, PhD, FAACR, on Advances in Kidney Cancer ResearchJune 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: